loading page

What Are The Factors That Affect Post COVID 1st Month's Continuing Symptoms?
  • +4
  • Berna Akinci Ozyurek,
  • Tugce Sahin Ozdemirel,
  • Esma Sevil Akkurt,
  • Derya Yenibertiz,
  • Tilbe Saymaz,
  • Sertac Buyukyaylaci Ozden,
  • Zehra Eroglu
Berna Akinci Ozyurek
Author Profile
Tugce Sahin Ozdemirel
Department of Chest Disease, University of Health Sciences Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara-Turkey.
Author Profile
Esma Sevil Akkurt
Department of Chest Disease, University of Health Sciences Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara-Turkey
Author Profile
Derya Yenibertiz
University of Health Sciences Keçiören Training and Research Hospital, Ankara-Turkey.
Author Profile
Tilbe Saymaz
Department of Chest Disease, University of Health Sciences Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara-Turkey.
Author Profile
Sertac Buyukyaylaci Ozden
Department of Chest Disease, University of Health Sciences Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara-Turkey.
Author Profile
Zehra Eroglu
Department of Chest Disease, University of Health Sciences Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara-Turkey.
Author Profile

Abstract

ABSTRACT Aim: The aim of our research was to investigate retrospectively the relationship between the symptoms and general characteristics, initial laboratory values and treatments in patients who had COVID- 19 and who applied to the chest diseases outpatient clinic for control after 1 month. Methods: Three hundred fifteen patients who were diagnosed with COVID- 19 and applied to the chest diseases outpatient clinic between May 2020 and August 2020 for control in the 1st month were included in the study. Patient information was collected from the hospital information system and the e-pulse system. Results: Females accounted for 50.2 % of the our patients and their mean age was 47.98 ± 14.81 (19-88) years. 14.3% (n: 45) of the individuals were 65 years of age and older. 20.6% (n: 65) of our patients were smoking. 70.2% (n: 221) of our patients were treated at home. 133 patients had at least one comorbid disease. The patients most frequently reported cough, dyspnea, weakness, myalgia and diarrhea. The most common symptoms were cough, dyspnea, weakness and myalgia in the first month. It was determined that the symptoms had persisted in patients who had been hospitalized, had dual therapy, had comorbid diseases and had more common pathologies in their pulmonary imagings. Conclusion: Symptoms may persist for a long time in hospitalized patients, in patients with COVID-19-related pneumonia and concomitant chronic diseases and in patients with high d-dimer and high CRP at the time of admission. Patients are informed that their symptoms may last for a long time, unnecessary hospital admissons can be avoided.

Peer review status:UNDER REVIEW

30 Jan 2021Submitted to International Journal of Clinical Practice
02 Feb 2021Submission Checks Completed
02 Feb 2021Assigned to Editor
16 Feb 2021Review(s) Completed, Editorial Evaluation Pending
16 Feb 2021Reviewer(s) Assigned
14 Apr 20211st Revision Received
16 Apr 2021Submission Checks Completed
16 Apr 2021Assigned to Editor
27 Apr 2021Reviewer(s) Assigned